Discovery of novel tacrine derivatives as potent antiproliferative agents with CDKs inhibitory property-Reference-Cited by-同舟云学术

Discovery of novel tacrine derivatives as potent antiproliferative agents with CDKs inhibitory property

Published:2022-09 Issue: Volume:126 Page:105875
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Liu Wenwu,Wu Limeng,Li Deping,Huang Yaoguang,Liu Mingyue,Liu Wenjie,Tian Caizhi,Liu Xin,Jiang Xiaowen,Hu Xiaolong,Gao Xudong,Xu Zihua,Lu Hongyuan,Zhao Qingchun

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference34 articles.

1. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type;Summers;N. Engl. J. Med.,1986

2. Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease;Watkins;JAMA,1994

3. Tacrine-based multifunctional agents in Alzheimer's disease: an old story in continuous development;Milelli;Curr. Med. Chem.,2017

4. Therapeutic agents in Alzheimer's disease through a multi-targetdirected ligands strategy: recent progress based on tacrine core;Lin;Curr. Top. Med. Chem.,2017

5. Tacrine inhibits topoisomerases and DNA synthesis to cause mitochondrial DNA depletion and apoptosis in mouse liver;Mansouri;Hepatology,2003

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting cyclin-dependent kinases: From pocket specificity to drug selectivity;European Journal of Medicinal Chemistry;2024-09

2. Connecting GSK-3β Inhibitory Activity with IKK-β or ROCK-1 Inhibition to Target Tau Aggregation and Neuroinflammation in Alzheimer’s Disease—Discovery, In Vitro and In Cellulo Activity of Thiazole-Based Inhibitors;Molecules;2024-06-02

3. Multi-Target-Directed Cinnamic Acid Hybrids Targeting Alzheimer’s Disease;International Journal of Molecular Sciences;2024-01-01

4. Development and structure-activity relationship of tacrine derivatives as highly potent CDK2/9 inhibitors for the treatment of cancer;European Journal of Medicinal Chemistry;2022-11

5. Discovery of novel benzofuro[3,2-b]quinoline derivatives as dual CDK2/Topo I inhibitors;Bioorganic Chemistry;2022-09